Fundamental changes in the regulations applied to the pharmaceutical industry, public opinion on standards of ethical behavior and the global economic situation make this a challenging time to be a compliance professional or legal counsel responsible for ensuring adherence to applicable laws, regulations and codes of practice within our industry.

The PCF International Pharma Congress brings together senior global compliance professionals and legal counsel from around the world to share experiences and best practices to clarify these changes and potential responses to them. In Europe, the new Pharma Package (which focuses on three key areas: anti-counterfeiting initiatives, pharmacovigilance and providing information for patients) was finally adopted in December 2008. In the USA, the newly revised PhRMA code and the new Obama administration are beginning to have a significant impact across the pharmaceutical industry. In Asia, governments are bringing in new legislation and / or enforcing existing legislation to dispel perceptions of corruption and / or conflicts of interest within the public sector.

Keynote speakers representing the IFPMA, European Commission and Patients will give their views on the changes affecting our industry and how pharmaceutical companies can make a real difference during these challenging times. Panel discussions will focus on transparency and international compliance. There will also be smaller track discussions on the new European Pharma Package, clinical trials in emerging markets and a selection of case study sessions.

If you want to find out how to manage compliance in these challenging times, the PCF International Pharma Congress will give you the information that you need.